The independent source for health policy research, polling, and news.
201 - 220 of 3,362 Results
The federal government’s hospital penalty program finishes its first decade by lowering payments to nearly half the nation’s hospitals for readmitting too many Medicare patients within a month. Penalties, though often small, are credited with helping reduce the number of patients returning for another Medicare stay within 30 days.
“Obstetrical emergency departments” are a new feature in some hospitals that can inflate medical bills for even the easiest, healthiest births. Just ask the parents of Baby Gus.
The state’s unique health system controls what hospitals can charge for services.
In this episode, we get our bearings on self-funded insurance plans, and how they affect the average — sometimes burned-out — American worker trying to get answers about insurance.
Like almost everything else associated with the covid-19 pandemic, partisans are taking sides over whether vaccines should be mandated. Meanwhile, Democrats on Capitol Hill are still struggling to find compromise in their effort to expand health insurance and other social programs. Alice Miranda Ollstein of Politico, Jen Haberkorn of the Los Angeles Times and Mary Ellen McIntire of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews best-selling author Beth Macy about her book “Dopesick,” and the new Hulu miniseries based on it.
Patients soon will not have to worry about the prospect of these often-costly unexpected bills, a federal law promises. Some experts say the new policy could also slow the growth of health insurance premiums.
But Americans generally have little confidence that the White House or Congress will recommend the right thing, a new poll shows.
In Maryland, it's now illegal for a hospital to sue a patient who qualifies for charity care. But in many other states, that's still a thing.
Officials are enthusiastic about the Allcove initiative, modeled on an Australian program. But it will need to show effectiveness and find funding.
Despite big 2020 campaign promises to deliver lower costs on prescription drugs, Democrats have failed to unite around a legislative plan.
Negotiations continue on Capitol Hill over President Joe Biden’s health agenda — along with a long list of other items. With Republicans on the sidelines, liberal Democrats delayed a House vote on a Senate-passed infrastructure bill to extract moderates’ support for a social-spending bill that includes expansions of benefits for Medicare, Medicaid and the Affordable Care Act. Meanwhile, the Biden administration’s new rules to prevent “surprise” medical bills pleases some health stakeholders and angers others. Alice Miranda Ollstein of Politico, Tami Luhby of CNN and Kimberly Leonard of Insider join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews Anna Flagg of the Marshall Project about how a century-old report on medical education contributed to racial inequities that persist today.
The condition can be an early signal of Alzheimer’s disease, but not always. Other health concerns could be causing thinking or memory problems, and the new drug, Aduhelm, would not be appropriate for those patients.
Coronavirus outbreaks have shuttered K-12 classrooms across the U.S., affecting tens of thousands of K-12 students. To avoid the same fate, some school districts are tapping federal dollars to set up testing programs and step up their vigilance against the virus.
Congress is back in session with a short time to finish a long to-do list, including keeping the government operating and paying its bills. Hanging in the balance is President Joe Biden’s entire domestic agenda, including major changes proposed for Medicare, Medicaid and the Affordable Care Act. Meanwhile, the new Texas abortion law that bans the procedure early in pregnancy is prompting action in Washington. Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Call and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews former FDA Commissioner Scott Gottlieb about his new book on the covid-19 pandemic.
Biologic drugs, made from living organisms, and the cheaper biosimilar drugs that mimic them are more complex than chemical drugs and their generic counterparts. The Food and Drug Administration says biosimilars are as safe and effective as the biologics, and doctors agree — but they are cautious about changing the treatment regimen of patients doing well.
Private agencies that bring young adults to the U.S. to care for children generally offer basic health insurance, but plans may exclude many types of necessary care. What the agencies might not mention is that au pairs are eligible to enroll in comprehensive coverage on the Affordable Care Act marketplaces and likely qualify for premium subsidies that would make the insurance affordable.
This episode highlights how New York enacted a charity care law, one of the precursors to the federal provision on charity care in the Affordable Care Act.
Democrats have hit a snag in their effort to compile a $3.5 trillion social-spending bill this fall — moderates are resisting support for Medicare drug price negotiation provisions that would pay for many of the measure’s health benefit improvements. Meanwhile, the new abortion restrictions in Texas have moved the divisive issue back to the political front burner. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat and Shefali Luthra of The 19th join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interview’s KHN’s Phil Galewitz about the latest KHN-NPR “Bill of the Month” installment, about two similar jaw surgeries with very different price tags.
The feds’ civil suit links exaggerated patient bills to “tens of millions” in overcharges.
Germans pay less than $1 per test. Brits get them free. Why do Americans pay so much more? Because companies can still demand it.
© 2026 KFF